May 2005

  

"ISPOR e-BULLETIN" provides updates of recent ISPOR activities and events. For detailed information on ISPOR activities, members are encouraged to go to www.ispor.org.

 

Please share these new ISPOR activities with your colleagues.

  eBulletin Index

May 2005

 

  

ISPOR e-BULLETIN provides updates of recent ISPOR activities and events. For detailed information on ISPOR activities, members are encouraged to go to www.ispor.org.

 

Please share these new ISPOR activities with your colleagues.

 

 

NEW THIS MONTH

**NEW** 2005-2006 ISPOR Board of Directors Election Results

**UPDATED** 10th Annual Meeting–Record Attendance (Register NOW, avoid waiting in line)
       **UPDATED** ISPOR Short Courses Prior to 10th Annual International Meeting–REGISTER NOW!

**NEW**Value in Health Vol. 8 No. 3 (May/June 2005) (Annual Meeting Abstract Issue now includes research papers)

**NEW** 8th Annual European Congress ABSTRACT SUBMISSION DEADLINE: 20 JUNE

**NEW** ISPOR 2nd Asia-Pacific Conference Info now on-line

       **NEW** Medication Compliance SIG Draft The Checklist For Medication Compliance Studies Using Retrospective Drug Utilization Data Available, now available for comments

 **NEW** ISPOR Special Interest Group (SIG) Updates

 **NEW** ISPOR 8th European Congress:  Exhibitor opportunities now on-line

 **NEW** 7 New Positions At The ISPOR Website

       **NEW** View Employment Positions Available at the ISPOR 10th Annual International Meeting Professional Recruitment Center (PRAP)

 

 ISPOR ONGOING ACTIVITIES

 

1.       Publications

2.       Meetings and Congresses

3.       Educational Activities

4.       Student News

5.       ISPOR Special Interest Groups

6.       Committee and Task Force Activities

7.       Hot Topics

8.       Important Dates to Remember

8.       Asia Consortium and Local Chapter News

10.    Employment in Pharmacoeconomics and Outcomes Research

11.    Membership

 


  1. PUBLICATIONS

Top

 

VALUE IN HEALTH

 

Value in Health: Volume 8, Issue 3, May/June 2005 will be online later this month at: http://www.ispor.org/valueinhealth_index.asp.  The following is the TABLE OF CONTENTS for Value in Health Volume 8, Issue 3, May/June 2005, which now features full-length research papers:

           

            Featured in this issue . . .

 

EMPIRICAL

COST-EFFECTIVENESS OF FIVE INTERVENTIONS FOR MEDICAL PROFESSIONALS TO AID PEOPLE TO STOP SMOKING

Talisha L. Feenstra, Heleen H. Hamberg-van Reenan, Rudolf T. Hoogenveen, P.M.H. Rutten-van Molken

 

Smoking increases the risk of a number of chronic diseases and cancers. Smoking cessation is therefore an interesting public health policy goal. It improves health and saves the costs of care for smoking related diseases. A number of studies stressed the low costs and high health returns of helping people to stop smoking. A recent study “Cost-effectiveness of Face-To-Face Smoking Cessation interventions: a dynamic modeling Study”  published in Value in Health in may 2005, reports on the costs and effects of five different interventions that medical professionals may apply to help people stop smoking. The study was a cooperation of the Institute for Medical Technology Assessment and the Dutch National Institute of Public Health and the Environment (RIVM). Talitha Feenstra and co-authors evaluated five effective interventions: a short stop smoking advice from a general practitioner, the same advice in combination with nicotine gum or patches, intensive counseling with nicotine gum or patches, intensive counseling with bupropion, and telephone counseling. The study was carried out to support the development of Dutch guidelines for medical professionals on smoking cessation.  “We found that in the Netherlands, the current use of smoking cessation advice by medical professionals was low.” says Feenstra, “Compared to current practice, widespread use of a short stop smoking advice from a general practitioner would generate both gains in health and savings in costs of care for smoking related diseased that were higher than the costs of the advice, while for the other interventions, the extra costs per life year gained were very low.” 

 

NATIONAL NEGOTIATIONS ARE REDUCING PRICES FOR HOSPITAL MEDICINES IN NEW ZEALAND

           

            June M. Tordoff, Pauline T. Norris, David M. Reith

 

Public hospitals are under financial pressure to contain pharmaceutical expenditure yet provide both established and innovative medicines for patients. In 2002, in an attempt to contain hospital drug expenditure, the New Zealand government agency PHARMAC began negotiating prices for some frequently used hospital medicines on behalf of all public hospitals. A recent study by Tordoff et al in the May/June 2005 issue of Value in Health examined the impact of the first year of this initiative. Using data provided by chief pharmacists from 11 hospitals (savings or costs for their Top150 items) the authors estimated projected savings of 3.7%, NZ$5.2m ($2.9m to $8.7m) for 2003/4 for all 29 major public hospitals. Two estimates for the 29 hospitals were obtained by extrapolating data from the 11 hospitals, using savings per bed, and savings per bed-day. Both estimates were similar. Smaller hospitals appeared to achieve better savings as a proportion of their expenditure. The main contributors to savings were agents for infections, the nervous system, musculoskeletal system, and blood/blood forming organs. The authors conclude that moderate cost savings have been achieved but suggest effects on patient outcomes and the range of medicines available may need monitoring in future.

 

ROUTINE VACCINATION OF CHILDREN AGAINST VARICELLA REDUCE MORBIDITY AND COSTS IN EUROPEAN COUNTRIES

 

Laurent Coudeville, Alain Brunot, Thomas D. Szucs, Benoit Dervaux

 

In many European countries, the debate over targeted vaccination versus mass vaccination remains open. In this context, the question of the value of varicella vaccination has been addressed in several economic evaluations over the last decade. Coudeville et al. from CRESGE – LABORES research unit in France analyzed the epidemiological and economic consequences of a routine vaccination strategy against varicella in children in two European countries: France and Germany. They used the same methodological framework which makes the results fully comparable. The model used is based on the varicella transmission model developed by Halloran. Given its dynamic nature, this model is able to assess direct as well as indirect effects of vaccination, i.e. herd immunity effects. The results of Coudeville et al.’s work were recently presented in the paper “The Economic Value of Childhood Varicella Vaccination In France And in Germany”, published in Value in Health (May/June 2005). According to their findings, achieving vaccination of 90% of a birth cohort would quickly result in a sharp decrease in the number of varicella cases and hospitalizations. A routine vaccination program would be cost-saving not only from a societal point of view of society but also from a payer’s perspective, in both countries. Catch up programs provide additional savings. These findings will be certainly of interest to health care decision makers.

 

            POLICY AND APPLICATION

FEDERAL SPONSORSHIP OF COST-EFFECTIVENESS AND RELATED RESEARCH IN HEALTH CARE: 1997-2001

 

Joanna E. Siegel, Sepheen C. Byron, William F. Lawrence

 

The U.S. Federal government has funded health economic studies for nearly two decades.  In their recent Value in Health article, “Federal Sponsorship of Cost-Effectiveness and Related Research in Healthcare: 1997-2001,” Siegel et al. examine a sample of this research to provide insight into the functioning of existing research support systems and to assess Federal health agency roles.  The authors reviewed 5 years of Federally-supported publications that address the cost-effectiveness of healthcare services. Six primary funders, the Agency for Healthcare Research and Quality, Centers for Disease Control and Prevention, Veterans Administration and three National Institutes for Health, contributed to three-fourths of the publications.  Publications citing Federal support focused on areas of high disease burden including infections, cancer, HIV/AIDS, cardiovascular disease, and substance abuse; however, other high-burden conditions, including mental health, diabetes, and injuries, were less well represented.  Federal support of health economic studies of health education and care delivery -- intervention areas generally under-examined in the field -- was comparatively strong but mainly addressed interventions in substance abuse and mental health services.  In general, Federal agencies supported projects consistent with their missions, but the authors found results suggestive of gaps and overlap that warrant improved coordination of Federal health economic research funding.

 

CONTRIBUTED PODIUM PRESENTATIONS

Value in Health; Volume 8, Issue 3, Page 237

CONTRIBUTED POSTER PRESENTATIONS: Session I

Value in Health; Volume 8, Issue 3, Page 258

CONTRIBUTED POSTER PRESENTATIONS: Session II

Value in Health; Volume 8, Issue 3, Page 338

DISCLOSURE INFORMATION

Value in Health; Volume 8, Issue 3, Page 420

AUTHOR INDEX

Volume in Health; Volume 8, Issue 3, Page 426

 

ISPOR CONNECTIONS

ISPOR CONNECTIONS: Volume 11, Issue 2, March/April 2005 is on-line at: http://www.ispor.org/news/index_new.asp

 

Featured in this issue: 

        The $64,000 Question: What Are We Willing To Pay for A QALY

        Cam Donaldson MD, University of Newcastle upon Tyne, Newcastle upon Tyne, UK

        (The second part of a 3-part series taken from the Third Plenary Session, Wednesday May         13, 2004, at the ISPOR 9TH Annual International Meeting, Arlington, VA, USA)

 

HEALTH CARE COST, QUALITY, AND OUTCOMES: ISPOR BOOK OF TERMS

 

“RTI Health Solutions clients appreciated receiving the ISPOR Book of Terms. They found it to be a valuable resource.” Graham Dyck, Director, Marketing and Business Development, RTI Health Solutions, Research Triangle Park, NC, USA.

 

This ISPOR publication includes more than 100 detailed monographs covering over 400 terms used in health care delivery, management, and regulation, as well as health care outcomes research including clinical, economic, and quality-of-life research terms. ISPOR member discounted price is $36.00; a 40% discount!  Student/Library/Academic discounted price: $33.00 (a 45% discount). On-line ordering is now available at: http://www.ispor.org/publications/lexicon_index.asp.  Contact Stephen Priori at spriori@ispor.org for information on orders over 1000. 

 


  

  1. ISPOR MEETINGS AND CONGRESSES

Top

   

**UPDATED**ISPOR 10TH ANNUAL INTERNATIONAL MEETING–RECORD ATTENDANCE!!

      May 15-18, 2005, Marriott Wardman Park Hotel, Washington, DC, USA

 

Over 600 contributed presentations (a 20% increase) at the ISPOR 10th Annual International Meeting!!!!! 26 workshops, 8 issues panels, 64 podium, and 520 contributed poster presentations.

 

For program information, go to: http://www.ispor.org/meetings/washington0505/index.asp

  

HOTEL RESERVATIONS, online reservations and additional information:

http://www.ispor.org/meetings/washington0505/hotel.asp

 

MEETING AT A GLANCE

http://www.ispor.org/meetings/washington0505/index.asp

   

PROFESSIONAL RECRUITMENT CENTER (PRAP)

Advertise employment opportunities: Careers

View positions posted at the 10th Annual International Meeting PRAP Center: http://www.ispor.org/meetings/washington0505/prap.asp (Bring your CV to the meeting to apply for these positions).

 

PRE-MEETING SYMPOSIUM: Evolution and Innovation of Pharmaceutical Technology: Implications for US Medicare Modernization Act co-sponsored by ISPOR and the PhRMA Health Outcomes Committee

Sunday, May 15, 2005, 5:00-7:00PM

Marriott Wardman Park Hotel, Washington DC, USA (Prior to the ISPOR 10th Annual International Meeting)

 

SYMPOSIUM: Methodological Issues in the Analysis of Health Care Databases sponsored by: IMS Health

Monday, May 16, 2005, 1:00-2:00PM

Marriott Wardman Park Hotel, Washington DC, USA (During the ISPOR 10th Annual International Meeting)

 

BERNIE O'BRIEN BENEFIT DINNER

     

      SUNDAY, MAY 15, 2005 7:30 PM – 10:30 PM

      We invite you to an evening of fine food and beverages as we explore the lighter side of ISPOR members and friends. This event honors the fun-loving spirit of Bernie J. O'Brien MSc, PhD, and supports the Bernie J. O'Brien New Investigator Award Endowment Fund and the Emma and Lucy O'Brien Trust Fund.

 

      For more information and to register for this, go to: http://www.ispor.org/meetings/washington0505/OBrien_benefit.asp

 JOIN US IN CELEBRATING THE ISPOR 10th ANNIVERSARY CELEBRATIONS!!

 

ISPOR celebrates its 10-Year Anniversary though out the 10th Annual International Meeting!  The schedule of celebratory events is as follows:

 

MONDAY, MAY 16

8:00-8:30 AM ISPOR: 10 YEARS – "PAST, PRESENT AND FUTURE"

 

12:30–2:00 PM ISPOR 10 YEARS CELEBRATION CAKE CUTTING CEREMONY

 

6:00-8:00PM ISPOR 10th ANNIVERSARY CELEBRATION AND GIFTS

 

TUESDAY, MAY 17

10:45-11:15 AM 10 YEAR MEMBERS' RECOGNITION

 

12:30PM–1:30PM ISPOR 10 YEARS CELEBRATION

 

5:00-7:00PM ISPOR 10th ANNIVERSARY CELEBRATION AND TOASTS   

 

7:30- 10:30 PM ISPOR 10th ANNIVERSARY PARTY at the Sequoia Restaurant on the Potomac River, open bar & food, DJ and dance floor, door prizes, quiz games, transportation to/from the Marriott Wardman Park Hotel.  Only $50 USD.

Register online: http://www.ispor.org/meetings/washington0505/anniv_party.asp

 

WEDNESDAY, MAY 18

10:30- 11:00AM ISPOR 10 YEARS PAST PRESIDENTS' RECOGNITION

 

**NEW** ISPOR EIGHT ANNUAL EUROPEAN CONGRESS

      6-8 November 2005 Palazzo Degli Affari, Florence , Italy

     “INCORPORATING VALUES INTO HEALTH CARE DECISIONS”

 

**Abstract Submission Deadline: 20 June 2005

June 20 at 11:59 PM US Pacific Daylight Savings Time is the deadline to submit an abstract for presentation at the ISPOR 8th Annual European Congress.  All abstract submissions are online:  http://www.ispor.org/congresses/italy1105/abstr_instr.asp

 

Contributed Research topics:

**Clinical Outcomes Studies

**Cost Studies

**Patient Reported Outcomes Studies (Quality of Life, Utility, Treatment/Patient/Work Satisfaction, Preference Studies)

**Health Care Use & Policy Studies

**Method Studies & Concepts

Contributed Workshop topics:

**Clinical study methodology issues including pharmacoepidemiology

**Cost study methodology issues

**Quality of life study methodology issues including patient reported outcomes

**Preference-based studies methodology issues including utility studies

**Drug/device coverage research issues

**Health care policy development issues using outcomes research

**Risk assessment/risk management issues

**Compliance issues

**Patient registry development issues

Contributed Issue Panel

Submissions are accepted on (but not excluded to) the following topics:

**Pharmacoeconomic / Health Economic Study Methodology Issues

**Quality of Life / Patient-Reported Outcomes Study Methodology Issues

**Utility (Preference-based) Study Methodology Issues

**Clinical Outcomes

**Health Policy

**Health Care Reimbursement / Coverage Issues

**Risk Assessment Study Issues

**Use of Health Economic/Pharmacoeconomic Information by Decision-Makers

 

First Plenary Session:

Patient Values and Societal Values: How to Measure and Compare Outcomes
and What Considerations for the Different Audiences

http://www.ispor.org/congresses/italy1105/100605.asp

 

Second Plenary Session:

Health Care Decision Makers Facing the Budget Allocation Dilemma:

Compressing Mortality vs. Compressing Morbidity

http://www.ispor.org/congresses/italy1105/100705.asp

 

Third Plenary Session:

The Value of Safety: A Critical Issue All Along the Development
and Marketing of Pharmaceuticals

http://www.ispor.org/congresses/italy1105/100805.asp

 

      Exhibitor Opportunities available at:

 

Sponsorship Opportunities available at:

 

For more details about the Congress, go to: http://www.ispor.org/congresses/italy1105/index.asp

 


 

  1. EDUCATION ACTIVITIES

Top

           

ISPOR SHORT COURSES

Saturday, May 14th & Sunday May 15th, 2005 - Prior to the ISPOR 10th Annual International Meeting

 

For short course descriptions and faculty information go to:

·       Saturday, May 14th: http://www.ispor.org/meetings/washington0505/sc14.asp

·       Sunday, May 15th: http://www.ispor.org/meetings/washington0505/sc15.asp

 

 

Pharmacoeconomics Courses:

·       Pharmacoeconomics for Decision-makers – Saturday Full Day Course (8:00am-5:00pm)

·       Elements of Pharmaceutical Pricing – Sunday Morning Course (8:00am-12:00pm)

 

Clinical Assessment Courses:

·       Retrospective Database Analysis: Econometric Methods – Sunday Full Day Course (8:00am-5:00pm)

·       Meta-Analysis and Systematic Literature Review – Sunday Morning Course (8:00am-12:00pm)

 

Modeling Courses:

·       Bayesian Analysis: Overview – Saturday Morning Course (8:00am-12:00pm)

·       Bayesian Analysis: Applications – Saturday Afternoon Course (1:00pm-5:00pm)

·       Modeling: Structure & Design of Model – Sunday Full Day Course (8:00am-5:00pm)

·       Discrete Event Simulation for Economic Analyses - Sunday Afternoon Course (1:00pm-5:00pm)

·       Introduction to Decision Analysis – Saturday Afternoon Course (1:00pm-5:00pm)

 

Quality of Life/Patient-reported Outcomes Courses:

·       Introduction to Quality of Life/Patient-Reported Outcomes – Saturday Afternoon Course (1:00pm-5:00pm)

·       Old and New Utility Measures in Health Economics and Outcomes Research – Sunday Morning Course (8:00am-12:00pm)

·       Advanced Quantitative Methods for Quality of Life/Patient-reported Outcomes Research – Sunday Afternoon Course (1:00pm-5:00pm)

 

Economic Analysis Courses:

·       Financial Impact / Cost of Illness – Saturday Afternoon Course (1:00pm-5:00pm)

·       Cost Estimation: Finding and Extracting Cost Data – Sunday Morning Course (8:00am-12:00pm)

·       Statistical Considerations in Economic Evaluations – Sunday Afternoon Course (1:00pm-5:00pm)

 

ISPOR Distance Learning Program Modules

ISPOR Distance Learning Program

  

The following module topics are currently available (total of 40 modules):

·      Pharmacoeconomics

·      Pharmacoeconomic Evaluations & Methods

·      Cost-Effectiveness Analysis

·      Cost-Benefit Analysis

·      Cost-Utility Analysis

·      Patient-Reported Outcomes (Utilities, Health-Related Quality Of Life, Treatment Satisfaction, Treatment Adherence, Patient Preferences)

·      Study Design in Pharmacoeconomics

·      Guidelines and Reference Standards

·      Pharmacoeconomics in Drug Development, Reimbursement and Marketing

 


 

  1. STUDENT NEWS

Top

 

Visit ISPOR Internship- Professional Recruitment Assistance Program (I-PRAP)

 

STUDENTS have the opportunity to search for internship positions available and post their CVs/resumes for employers to view. Post your CV today!

EMPLOYERS have the opportunity to access CVs/resumes from interested students.

 

For more details on the ISPOR Student Network, please visit: http://www.ispor.org/student/student_index.asp        


  

  1. ISPOR SPECIAL INTEREST GROUPS (SIG)

Top

 

VALUE-BASED REIMBURSEMENT SIG

 

Value-based Reimbursement SIG Open Meeting: Tuesday, May 17, 5:00 – 6:00 PM
The mission, working groups, leadership and future activities of the SIG will be presented.
Open to all meeting participants.
Speaker:
Diane L. Simison PhD, Chair, Value-based Reimbursement SIG and Executive Director, MEDTAP Institute at UBC, Center for Pricing and Reimbursement.

 

**NEW** Working Group Chairs:

· Evidence and Payer Decision-making Working Group
Nancy Risebrough
Senior Associate, HOPE Research Centre, Toronto, Ontario,
Michael Halpern MD, MPH, PhD, Chief Scientist, Exponent, Alexandria, VA

· Global Reimbursement Strategies Working Group
Geoffrey Wilson DPhil, BSc, MSc, PhD, Managing Director, ValuemoniX, Penn, UK  
Jennifer Stephens PharmD, Senior Clinical Consultant, PharMerit, Bethesda, MD USA

· Global Reimbursement Trends Working Group
Stefan Holmstrom BSc, MSc
, Manager, Strategic Pricing & Reimbursement, Allergan, Biot, France
Kevin Mayo PhD, Head, Global Strategic Pricing & Health Economics (NS & ID), Novartis Pharmaceuticals, Basel, Switzerland

· Reimbursement Literature Working Group
Paul Trueman MA, Sales & Marketing Director, York Health Economics Consortium, University of York, Heslington, York, UK
Parthiv Mahadevia MD, MPH, Associate Director, Payment and Coverage Group, Amgen, Inc., Washington, DC, USA

· Payer-oriented Evidence Guidelines Working Group
James Mackay MD
, Medical Director, Providence Health Plans, Beaverton, OR, USA
Joseph Singer MD, Vice President, HealthCore, Inc, Wilmington, DE, USA

 

For more details on this SIG, please visit: http://www.ispor.org/sigs/reimbursement.asp

 

HEALTH TECHNOLOGY ASSESSMENT SIG

 

Health Technology Assessment SIG Open Meeting on Monday, May 16 at 5:30 PM
The mission, working groups, leadership and future activities of the SIG will be presented.
Open to all meeting participants.
 

Speaker: Frank Papatheofanis MD, MPH, PhD, Chair, Health Technology Assessment SIG and Director of the Advanced
Medical Technology Assessment & Policy Program and Associate Professor of Radiology and Economics
University of California at San Diego

**NEW** Working Group Chairs

 

· HTA Methodology Working Group

Francis Pang BSc, MSc, PhD, Head of Health Economics, Abbott Laboratories, Maidenhead, UK
Alan Barkun MD, Director, Division of Gastroenterology, McGill University Health Centre, Montreal General Hospital,
Montreal, QC, Canada

· HTA in Reimbursement Economics Working Group

Jalpa Doshi PhD, Health Services Research Scientist, General Internal Medicine, University of Pennsylvania, Philadelphia, PA USA

Bonnie Handke RN, Sr. Reimbursement Manager, Medtronic, Minneapolis, MN, USA

 

· Applied HTA Working Group

Uwe Siebert MD, MPH, MSc, Director, Cardiovascular Research Program, MGH Institute for Technology Assessment, Harvard Medical School, Boston, MA, USA

Philip Booth MS, Director of Health Technology Appraisal, Novartis Pharmaceuticals, Frimley, Camberley, UK

 

· HTA to Support Marketing Initiatives Working Group

Sheryl Szeinbach BS, MS, PhD, RPh, Professor, College of Pharmacy, Ohio State University, Columbus, OH, USA

Noreen Sullivan BS, Vice President, Aequitas, San Diego, CA, USA

 

For more details on this SIG, please visit: http://www.ispor.org/sigs/hta.asp

 

CLINICAL PRACTICE SIG

 
Clinical Practice SIG Forum:
Tuesday May 17, 4:00– 5:00 PM, at the ISPOR 10th Annual International Meeting.  

Topic: Applying Pharmacoeconomic Principles in Clinical Practice . . . Noble Enterprise or Pipe Dream?    
   and
the Value Proposition to Payers & Providers:  Do Pharmacoeconomic Studies Meet the Needs of Decision Makers?

Stakeholder perspectives (payer, hospital and individual provider) will be presented and real-world examples of how outcomes research and pharmacoeconomic principles are applied across different medical centers, in Pharmacy & Therapeutics Committees and how patient outcomes can be used to develop practice guidelines and evaluate treatment outcomes.   

We will close with an audience discussion about restrictions that currently prevent the widespread usage of outcomes research and pharmacoeconomics in decision making along with suggested measures to take to change the current situation.   

Moderator: Ramon Bautista MD, MBA, Department of Neurology, University of Florida HSC Jacksonville, FL, USA;   Speakers: F. Randy Vogenberg RPh, PhD, Senior Vice President & National Practice Council Leader, Aon Consulting, Life Sciences Consulting Practice, Providence, RI, USA; Sara Shull MBA, PharmD, Drug Policy and Economics Pharmacist Specialist, Nebraska Health System Name, Omaha, NE, USA; Peter K. Wong PhD, MBA, RPh Vice President, Clinical Effectiveness & PI, Good Samaritan Hospital, Dayton, OH,USA.

 

Clinical Practice SIG Workshop: Monday, May 16, 2:00 – 3:00 PM during the ISPOR 10th Annual International Meeting. 
Topic: Standardized Reporting Format for Outcomes Research or Economic Evaluation and a System to Measure the Strength of Evidence of Studies

 

Speakers: Peter K. Wong PhD, MBA, RPh, Vice President, Clinical Effectiveness & PI, Good Samaritan Hospital, Dayton, OH, USA; Alan Bakst MBA, PharmD, Director, Health Economics and Outcomes Research, TAP Pharmaceutical Products Inc, Chicago, IL, USA; Alan Mutnick PharmD, Assistant Director Clinical Practice, University of Virginia Health System, Charlottesville, VA, USA.

 

For more details on this SIG, please visit: http://www.ispor.org/sigs/sigsindex.asp

 

PATIENT REGISTRY SIG

 

Patient Registry SIG Forum, Monday, May 17, 4:30 – 5:30 PM, at the ISPOR 10th Annual International Meeting. 


Topic: Patient Registries: Opportunity and Responsibility

Key issues will be discussed, including the industry’s role in sponsoring post-approval registries that capture “real world” clinical, economic, and humanistic data and other evaluations critical for a more accurate characterization of how drugs and devices are utilized in actual medical practice.  In addition, the findings from the Patient Registry survey will be presented and the Working Group Chairs will comment on issues involving commercialization, safety surveillance, analytical methods, technology, and global initiatives.  The session will include an open forum to solicit ISPOR member comments.


Moderator
: Jeffrey Trotter MM, President, Ovation Research Group, Highland Park, IL Speakers: Melva T. Covington MPH, MBA, PhD, Team Leader, Global Health Outcomes
Eli Lilly and Company, Indianapolis, IN, USA; Mohan Bala PhD, Director, Outcomes Research Centocor, Inc, Malvern, PA, USA: Peter Malamis MBA, Vice-President & General Manager, Post-Marketing Business Unit, Scirex, Horsham, PA, USA; Hugh Levaux PhD, CEO, Ninaza, San Mateo, CA, USA; Leanne Larson MHA, Vice President, Strategy & Development, Ovation Research Group, Highland Park, IL, USA.

 

For more details on this SIG, please visit: http://www.ispor.org/sigs/patient_registr.asp

 

QUALITY OF LIFE SIG

 

Quality of Life SIG Forum: Tuesday, May 17, 4:00 – 5:00 PM


Topic: Health Status and Patient Reported Outcomes / Quality of Life Measures in the ‘Real World'


Moderator: Pennifer Erickson PhD, Co-founder, O.L.G.A., State College, PA, USA; Benefits of Using ‘Real World’ Quality of Life/Patient Reported Outcomes, Speaker: Mary Cifaldi RPh, PhD Assistant Director, Abbott Laboratories, Abbott Park, IL, USA; Challenges and Limitations of ‘Real World’ Quality of Life/Patient Reported Outcomes, Speaker: Richard Chapman PhD, Director, Health Economics, ValueMedics Research, Alexandria, VA, USA; Methods and Best Practices for ‘Real World’ Quality of Life/Patient Reported Outcomes Studies, Speaker: Jamie Banks MS, Health Outcomes Strategy Group, Boston, MA, USA; Next Steps for ISPOR, Speaker: Andreas Pleil PhD, Director/Site Leader Worldwide Outcomes Researchomics, Pfizer Incorporated, San Diego, CA, USA;

 

Quality of Life SIG Open Meeting: Tuesday, May 17 5:00 – 6:00 PM

The mission, working groups, leadership and future activities of the SIG will be presented. Open to all meeting participants.

 

Speaker: Judith Barr PhD, Associate Professor, Northeastern University & Director, National Education and Research Center for Outcomes Assessment, Boston, MA, USA.

 

For more details on this SIG, please visit: http://www.ispor.org/sigs/qol.asp

 
MEDICATION COMPLIANCE SIG

    

10th Annual International Meeting Activities:

Monday, May 16th at 4:30pm – 5:30pmALL WELCOME!

 

Three workshops will be presented:

 

W1 Methods for Medication Compliance Studies: An Overview of the ISPOR Medication Compliance SIG Guidelines, Monday, May 16, 2:00 – 3:00 PM

 

W8 Medication Compliance (Adherence): issues and Definitions Consensus Workshop 2005, 3:15 – 4:15 PM.

 

W15 Methods for Medication Compliance Studies: The Importance of Statistical Distributions, Tuesday, May 17, 2005, 1:30 – 2:30 PM.

**NEW**Analyses Standards WG: 

A draft checklist for Medication Compliance Studies Using Retrospective Drug Utilization Data is available at http://www.ispor.org/sigs/eval_checklistdraft.asp. Please forward all comments to medcompsig@ispor.org

 

For more details on this SIG, please visit: http://www.ispor.org/sigs/medication.asp

 

RETROSPECTIVE DATABASE SIG

Retrospective Database SIG Forum: Tuesday, May 17, 4:00 – 5:00 PM
During this forum, the development of the ISPOR Digest of International Databases for Pharmacoeconomics and Outcomes Research will be presented.

 

Speakers: Carl Asche PhD, Co-Chair, Classification of Databases Working Group & Associate Professor, University of Utah, Salt Lake City, UT, USA; Gordon Cummins MS, Co-Chair Classification of Databases Working Group & Vice President, Sales & Account Management, HealthCore, Inc.

 

Retrospective Database SIG OPEN MEETING: Tuesday, May 17 5:00PM

This Open Meeting is a continuation of the Retrospective Database SIG Forum to provide an opportunity for attendees to comment on how to find these database organizations and the right questions to ask for information about the types of databases (questionnaire form).

Speakers:  Carl Asche PhD, Co-Chair Classification of Databases Working Group & Associate Professor, University of Utah, Salt Lake City, Utah; Gordon Cummins MS, Co-Chair Classification of Databases Working Group & Vice President, Sales & Account Management, HealthCore, Inc.

 

For more details on this SIG, please visit: http://www.ispor.org/sigs/retrospective_db.asp

 

RISK MANAGEMENT SIG

 

The Risk Management SIG is presenting two workshops:

W7 BALANCING RISKS AND BENEFITS OF HEALTHCARE TREATMENTS IN THE 21ST CENTURY, Monday, May 16, 2005, 2 – 3 PM.

The workshop will explore and comment on the areas of risk/benefit assessment, offering interesting material on how to balance the two.  A fascinating and interactive group case study will be performed following the presentation.

 

Speakers: Dennis Raisch (SIG Chair), VA Cooperative Studies Program, Albuquerque, NM, USA; Larry Liu (Co-chair, Identification Working Group), Pfizer Global Pharmaceuticals, New York, NY, USA; Paul Stang (Co-chair, Intervention/Implementation, Communication Working Groups), Associates, Inc. and West Chester University, Blue Bell, PA, USA; Ateequr Rahman (Co-chair, Communication Working Group), Shenandoah University, Winchester, VA, USA; Anthony Lockett (Co-chair, Intervention/Implementation Working Group), ICO, Leeds, W Yorkshire, UK; and Nicholas Lipskiy (Co-chair, Identification Working Group), Surveillance Data Inc, Plymouth Meeting, PA, USA.

 

W14 ISPOR MEMBER PERSPECTIVES: HOW DO INDIVIDUALS PERCEIVE RISKS AND BENEFITS OF PHARMACEUTICALS IN COMPARISON WITH OTHER NON-MEDICAL ACTIVITIES Monday, May 16, 2005, 3:15 – 4:15 PM.

This workshop will expose and analyze the results of a healthcare survey given to ISPOR membership.  Interesting findings include: US v. non-US comparisons of risk assessment, the amount of effect that individual side-effect experiences had on the perception of risk associated with other pharmaceuticals, and much more!

 

Speakers: Dennis Raisch (SIG Chair), VA Cooperative Studies Program, Albuquerque, NM,    USA; Larry Liu (Co-chair, Identification Working Group), Pfizer Global Pharmaceuticals, New York, NY, USA; Paul Stang (Co-chair, Intervention/Implementation, Communication Working Groups), Associates, Inc. and West Chester University, Blue Bell, PA, USA; Ateequr Rahman (Co-chair, Communication Working Group), Shenandoah University, Winchester, VA, USA; Anthony Lockett (Co-chair, Intervention/Implementation Working Group), ICO, Leeds, W Yorkshire, UK; and Nicholas Lipskiy (Co-chair, Identification Working Group), Surveillance Data Inc, Plymouth Meeting, PA, USA.

 

For more details on this SIG, please visit: http://www.ispor.org/sigs/rm.asp

 

MANAGED CARE SIG

 

For more details, please visit: http://www.ispor.org/sigs/sigsindex.asp

 

Special Interest Group membership is open to ALL ISPOR members. To JOIN any SIG: http://www.ispor.org/sigs/joinsig.htm

 


  1. ISPOR BOARD, COMMITTEE, AND TASK FORCE ACTIVITIES

Top

           

AWARD COMMITTEE ACTIVITIES

 

2005 ISPOR AVEDIS DONABEDIAN OUTCOMES RESEARCH LIFETIME ACHIEVEMENT AWARD RECIPIENT

 

The recipient of this year's award is Katherine N. Lohr, PhD, MPhil, MA of RTI International, Durham NC, USA. 

 

2005 ISPOR BERNIE O'BRIEN NEW INVESTIGATOR AWARD RECIPIENT

 

The first recipient of this new annual ISPOR award is Shelby D. Reed, PhD, RPh, of Duke Clinical Research Institute, Raleigh, NC, USA.

 

2005 ISPOR RESEARCH EXCELLENCE AWARD RECIPIENTS

 

The recipient of the 2005 ISPOR Research Excellence Award for Methodology Excellence is Joshua Salomon PhD, Assistant Professor of International Health, Harvard Center for Population and Development Studies, Cambridge, MA, USA, for his paper, "A Multi-Method Approach to Measuring Health-State Valuations." Health Econ 2004;13:281-90.

 

The recipient of the 2005 ISPOR Research Excellence Award for Practice Application Excellence is Sebastian Schneeweiss MD, ScD, Assistant Professor of Medicine and Epidemiology, Harvard Medical School and Harvard School of Public Health, Boston, MA, USA, for his paper, "Clinical and Economic Consequences of a Formulary Restriction of Nebulized Respiratory Drugs in Adults: Direct Comparison of Randomized and Observational Evaluations." Br Med J  2004;328:560-4.

 

The recipients of these and other ISPOR Awards will be presented their award at the ISPOR 10th Annual International Meeting in Washington, DC on May 17, 2005.

 

For more details, please visit: http://www.ispor.org/awards/index_.asp

 

ISPOR TASK FORCE: USING "REAL WORLD" DATA IN COVERAGE AND REIMBURSEMENT DECISIONS

  

The Real World Task Force Working Groups (Evidence Hierarchy, Clinical Outcomes, Economic Outcomes, and Patient Reported Outcomes) continue to put forth great efforts in their mission to: 1) identify the issues (related to using and interpreting "real world" data); 2) develop a best practices document (a white paper) with a collaborative submission to Value in Health tentatively scheduled for July 2005; and 3) develop an action plan for outreach and communication. 

 

For more details, including a draft outline of this final paper, and a list of core group members, go to: http://www.ispor.org/workpaper/real_world_data.asp

 

NOMINATIONS COMMITTEE

 

**NEW** 2005 ISPOR Board of Directors Election Results

 

The new elected members of the ISPOR Board of Directors will take office on July 1, 2005.  They are:

 

2005-2006 President-elect and 2006-2007 President

Michael Drummond PhD, Director, University of York, Centre for Health Economics, Heslington, York, UK

 

2005-2007 Directors

Joyce Cramer, Associate Research Scientist, Yale University School of Medicine, 950 Campbell Avenue, West Haven, CT, USA

 

Scott Ramsey MD, PhD, Associate Member, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue North  M2-B230,  Seattle, WA, USA

 

These board members will join the incumbent Board members:

 

2005-2006 President

Peter J. Neumann, ScD, Associate Professor of Policy and Decision Sciences, Harvard School of Public Health, Boston, MA, USA

 

2004-2005 Past President

Lieven Annemans PhD, Director, HEDM, Meise, Belgium

 

2004-2006 Directors

Isao Kamae MD, DrPH, Professor of Biostatistics and Health Decision Sciences, Kobe University, Kobe, Japan

 

Capt. Laurie Beth Burke, RPh, MPH, Director, Study Endpoints and Label Development, Office of New Drugs, CDER, FDA, Rockville, MD, USA

 

Jens Grueger PhD, Head of Pricing and Health Economics, Novartis Pharmaceuticals, Basil, Switzerland  


  1. HOT TOPICS

Top

 

MEDICARE ANNOUNCES FUNDING FOR HEALTH INSURANCE COUNSELING PROGRAMS FOR 2005–SHIPS AWARDED $31.7 MILLION TO HELP INFORM BENEFICIARIES ABOUT NEW DRUG COVERAGE

 

April 11, 2005 – Today the Centers for Medicare & Medicaid Services (CMS) announced a 50 percent increase in funding for the State Health Insurance Assistance Programs (SHIPs).  SHIPs are a key partner in Medicare’s Education and Outreach effort to insure that everyone with Medicare knows they are eligible for prescription drug coverage, that they will have a choice of at least two plans, and that there will be extra assistance for those in need.

 

For full text of the article, see: http://www.cms.hhs.gov/media/press/release.asp?Counter=1426


 

  1. IMPORTANT DATES TO REMEMBER

Top

  

May 15-18, 2005 ISPOR 10th Annual International Meeting, Marriott Wardman Park Hotel, Washington, DC.

 

June 20, 2005 Abstract Submission deadline for the ISPOR 8th Annual European Congress.

 

1 July 2005 Abstract Submission begins for the ISPOR 2nd Asia-Pacific Congress.

 

8-11 November 2005 – ISPOR 8th European Congress, Palazzo Degli Affari, Florence, Italy


 

  1. ASIA CONSORTIUM AND LOCAL CHAPTER NEWS

Top

 

ISPOR ASIA CONSORTIUM

 

For more details on this consortium, please visit: http://www.ispor.org/consortiums/asia.asp

 

For more details on ISPOR local chapters, please visit: Regional Chapters

 

**NEW** ISPOR 2ND ASIA-PACIFIC CONFERENCE

The ISPOR 2nd Asia-Pacific Conference will be held in Shanghai, China, 5-7 March 2006. Abstract submission begins 1 July 2005 and ends 3 October 2005.  Early registration deadline is 5 February 2006.

 

For more details on the 2nd Asia-Pacific Conference, please visit: http://www.ispor.org/conferences/shanghai0306/index.asp


  1. EMPLOYMENT

Top

**NEW** 7 NEW POSITIONS AT THE ISPOR WEBSITE: Careers

 

Advertise your positions on ISPOR Website (~1 million hits per month)

 

**NEW** PROFESSIONAL RECRUITMENT CENTER (PRAP) – Twenty-four top positions already posted with the Center, scheduled to reach over 1,000 candidates!

Advertise employment opportunities: Careers

View positions posted at the 10th Annual International Meeting PRAP Center http://www.ispor.org/meetings/washington0505/prap.asp Bring your CV to the meeting to apply for these positions!

 

INTERNSHIPS

Visit ISPOR's Internship-Professional Recruitment Assistance Program (I-PRAP) at

 

STUDENTS: Post your CVs/resumes for employers to view and search for internship positions available. 
Nine student resumes posted!
 

 

EMPLOYERS: Post your Intern positions for FREE and access CVs/resumes from students.

 

If you have any questions, please contact: iprap@ispor.org.


 

  1. ISPOR MEMBERSHIP

Top

 

Update your email address at https://www.ispor.org/members/MemberProfile.aspx! Your email address is required as part of your log in information in the members only section of the ISPOR website.

 



eBulletin Index